This Privacy (this Policy”) describes how Dextrols Systems Pvt Ltd. and its subsidiaries with approved links to this Policy (jointly and variously known herein as, Dextrols Technologies”, Dextrols”, "Bol Messenger", "Bol", us”, our” or we”) collect, shop, use and reveal Private Information (described under) from persons (a) who utilize the website found at, and/or all other sites of Dextrols with certified links for this Plan (the Sites”), or (w) who use our services or products with licensed links for this Plan, including but not restricted to our Bol Messenger solution and any other request that individuals offer (the Products”). It doesn't affect employee info or corporate or organization information.
Biosense belonged to the first batch of startups incubated by GSF India and Rajesh Sawhney-promoted Global Super Angels Forum put in $150K in the company in March 2012. As part of that investment, Samir Sood, a member of the Global Super Angels, also joined the board of the company. Biosense had earlier secured seed funding from the Echoing Green Foundation and Chennai-based Villgro, an organisation that invests in early-stage social startups.
The following additional terms and conditions apply to you if you are using a copy of Bol Messenger that was downloaded from the Android/Apple/Windows App Store. To the extent the other terms and conditions of this Agreement are less restrictive than, or otherwise conflict with, the terms and conditions of this Section 10, the more restrictive or conflicting terms and conditions in this Section 10 apply, but solely with respect to copies of Bol Messenger downloaded from Android/Apple/Windows iTunes.
Biosense currently has a team size of 10 and it has developed a portable gadget called ToucHb that measures the haemoglobin count without the prick of a needle, to help detect anaemia. The company is now looking to launch (in April 2013) its latest uChek app that will enable physicians and Bol patients to analyse urine samples using their smartphones - measuring up to 10 parameters such as glucose, ketones and leukocytes. The startup follows a B2B model and sells these devices to clinics/medical facilities, who in turn earn recurring revenues by charging patients for each test.
We are focused to be a customs solution provider and constantly strive towards prompt delivery, effective purchases and professional customer service by investing in supply chain and information technology systems. We are committed to provide superior support and quality technical services with application solutions.
